Reported relationships
Latest disclosed role at each company.
No relationships currently tracked through insider filings.
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
No balances currently tracked through insider filings.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ChronoScale Holdings Corp
Report date October 02, 2026 · Filed October 06, 2026
Section 16 reporting ended · disclosed 2026-10-06. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 239,760 |
Reported balance
After 2026-10-02 transaction · row 1
1 source rowRow 1 · 2026-10-02 · Grant · Acquired 51,626 · Balance 239,760 F1: The restricted stock units ("RSUs") were granted on October 2, 2026 in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary of ChronoScale Holdings Corporation (the "Issuer"), and vested in full on the grant date. Effective as of October 3, 2026, the Reporting Person resigned as a member of the board of directors of the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer and has no expiration date. F2: Settlement of the RSUs has been deferred in accordance with the terms of the award agreement. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) | 373 |
Reported balance
Holding disclosure · report date 2026-10-02 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 373 |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units ("RSUs") were granted on October 2, 2026 in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary of ChronoScale Holdings Corporation (the "Issuer"), and vested in full on the grant date. Effective as of October 3, 2026, the Reporting Person resigned as a member of the board of directors of the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer and has no expiration date.
F2: Settlement of the RSUs has been deferred in accordance with the terms of the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 02, 2026 Filed Oct 6, 2026 22:19 UTC | ChronoScale Holdings Corp CHRN · Entity 4331 | GrantCommon Stock | 51,626 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-046032 · ownership.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 239,760 F1 · shares: The restricted stock units ("RSUs") were granted on October 2, 2026 in connection with the consummation of the disposition of Ekso Bionics, Inc., a wholly owned subsidiary of ChronoScale Holdings Corporation (the "Issuer"), and vested in full on the grant date. Effective as of October 3, 2026, the Reporting Person resigned as a member of the board of directors of the Issuer. Each RSU represents the right to receive one share of common stock of the Issuer and has no expiration date. F2 · shares: Settlement of the RSUs has been deferred in accordance with the terms of the award agreement. Read SEC document |
| May 14, 2026 Filed May 18, 2026 22:00 UTC | ChronoScale Holdings Corp CHRN · Entity 4331 | GrantCommon Stock | 109,357 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-024262 · ownership.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 188,134 F1 · shares: The shares of common stock of ChronoScale Corporation (the "Issuer") were acquired upon vesting of performance-based restricted stock units granted to the Reporting Person on November 5, 2025 under the Issuer's Amended and Restated 2014 Equity Incentive Plan, which were amended on May 14, 2026. Read SEC document |
| November 10, 2025 Filed Nov 12, 2025 22:04 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | SaleCommon Stock | 23,315 | $4.80 | $111,912.00 |
DisclosureSEC source: 0001437749-25-034502 · rdgdoc.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 78,777 F1 · shares: Represents shares sold by the Reporting Person on November 10, 2025 to cover tax withholding obligations incurred upon the vesting and settlement of restricted stock awards originally reported by the Reporting Person in Form 4 filed with the Commission on November 7, 2025. F2 · price: These shares were sold in a single transaction at a price of $4.7990 per share. F3 · balance_after: On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| November 05, 2025 Filed Nov 7, 2025 22:48 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-25-033905 · rdgdoc.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,092 F1 · shares: Represents restricted stock units ("RSUs"). Each RSU represents the economic equivalent of one share of EKSO common stock and shall be settled in shares of EKSO common stock upon vesting. F2 · shares: The RSU grant was approved by the Board of Directors in a meeting held on November 5, 2025, under the Company's Amended and Restated 2014 Equity Incentive Plan (the "Plan"). Each RSU Award was fully vested at grant. F3 · balance_after: On June 2, 2025, the Issuer effected a 1-for-15 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split. Read SEC document |
| March 14, 2025 Filed Mar 18, 2025 22:06 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 5,590 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001437749-25-008292 · rdgdoc.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · CEO 10b5-1 filing: No plan indicated Ownership: Indirect · By 401(k) Disclosed balance after: 5,590 F1 · price: These shares of common stock were acquired in connection with the Issuer's 401(k) contribution matching program. Read SEC document |
| August 17, 2023 Filed Aug 19, 2023 01:44 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | SaleCommon Stock | 37,446 | $1.00 | $37,281.24 |
DisclosureSEC source: 0001549084-23-000061 · wk-form4_1692409439.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 331,372 F1 · shares: Represents shares sold by the Reporting Person on August 17, 2023 to cover tax withholding obligations incurred upon the vesting and settlement of the restricted stock awards. F2 · price: These shares were sold in a single transaction at a price of $0.9956 per share. Read SEC document |
| June 30, 2022 Filed Jul 6, 2022 01:39 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | SaleCommon Stock | 4,997 | $1.72 | $8,594.84 |
DisclosureSEC source: 0001908860-22-000002 · wf-form4_165707154717564.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,818 F1 · shares: Represents shares sold by the Reporting Person on June 30, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of a restricted stock award originally reported by the Reporting Person in Form 3 filed with the Commission on February 3, 2022 F2 · price: These shares were sold in a single transaction at a price of $1.72 per share. Read SEC document |
| May 25, 2022 Filed May 26, 2022 20:33 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 300,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-032210 · doc4.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,815 F1 · security: Represents restricted stock units ("RSUs"). F2 · date: The RSU grant was approved by the Compensation Committee of the Board of Directors on May 25, 2022. F3 · shares: 1/3 of the total number of shares of Common Stock subject to the RSUs will vest on January 21st of each year beginning in 2023. Read SEC document |
| April 20, 2022 Filed Apr 26, 2022 21:13 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | SaleCommon Stock | 4,043 | $2.62 | $10,582.96 |
DisclosureSEC source: 0001209191-22-025648 · doc4.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 73,815 F1 · shares: Represents shares sold by the Reporting Person on April 20, 2022 to cover tax withholding obligations incurred upon the vesting and settlement of the first installment of restricted stock awards originally reported by the Reporting Person in a Form 4 filed with the Commission on February 22, 2022. F2 · price: The sale price represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $2.61 to $2.63, inclusive. The Company can provide the full information regarding the number of shares sold at each separate price upon further request. Read SEC document |
| February 17, 2022 Filed Feb 23, 2022 00:36 UTC | ChronoScale Holdings Corp EKSO · Entity 4331 | GrantCommon Stock | 41,158 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-011959 · doc4.xml · nonDerivative · entry 1 Davis Scott G. · CIK 0001908860 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,858 F1 · shares: Shares acquired pursuant to a restricted stock units award granted on April 8, 2021 that had both performance-based and time-based vesting conditions. The performance-based vesting conditions have been satisfied, and now the award is subject only to time-based vesting conditions. The award vests in three equal annual installments beginning on April 8, 2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.